Predicting future risk of dementia in patients using AI
SupportBrain®
Providing opportunities to start preventing dementia through technology that motivates better lifestyles
Produced by
ERISACo., Ltd.
- Top page
- Innovations from Shimane
- SupportBrain®
Difficulties in Preventing Dementia
Cognitive decline progresses slowly over time. Dementia is a condition in which cognitive decline interferes with daily life. Dementia causes irreversible cognitive decline, making early detection extremely important for prevention and treatment. However, early symptoms of dementia may present as other age-related changes, often preventing early detection.
Dementia is becoming a global issue with more than 55 million people diagnosed worldwide. Experts expect this number to reach 65 million by 2030 and to triple to over 152 million by 2050*1, increasing future demand for testing and prevention.
In response, we must make highly accurate information on the risk of dementia, appropriate prevention methods, and risk factors available to as many people as possible.
*1: Estimation by the Health Metrics and Evaluation, University of Washington School of Medicine, 2021.
SupportBrain® helps solve issues preventing dementia.
- Analyze the entire brain, not only the hippocampus and the entorhinal cortex
- Receive a report within 30 minutes if head MRI scan meet the imaging requirements
- Increase interest in preventing dementia and motivation to improve personal lifestyles through learning about future risk
SupportBrain® Features and Usage
ERISA Co., Ltd. collaborated with Shimane University School of Medicine and Shiga University of Medical Science to develop a new service to test for dementia called SupportBrain®. AI technology predicts the risk of dementia by analyzing the brain via MRI scans uploaded to the cloud. SupportBrain® is highly accurate, analyzing the entire brain against a vast amount of data.
Japan faces an advanced aging population. SupportBrain® is a Japanese technology that utilizes specialized AI developed for early prevention.
Requirements
Head MRI Scans
Imaging requirements: MRI magnetic field strength of 1.5 Tesla or 3.0 Tesla and 3D-T1-weighted images with 1 mm sagittal slices
Computer
Users must have access to a computer with internet access. The operating system is limited to Windows (64bit).
Installing SupportBrain® in Medical Facilities
- Confirm security policies of your devices
- Provide email address
- Analyze samples
- Complete installation
Before we install SupportBrain®, we check your MRI equipment, imaging method, and internet access. Once we confirm installation requirements, we will create an account and install the equipment. To complete the installation, we use sample images from your equipment to confirm SupportBrain® operates properly.
Advantages of SupportBrain®
1.Analyze the entire brain
Conventional dementia risk testing with image diagnosis only analyzes atrophy in the hippocampus or other selective parts of the brain. ERISA worked with Shimane University School of Medicine and Shiga University of Medical Science to develop SupportBrain®, which analyzes the entire brain. SupportBrain® tests based on large amounts of AI data, precisely analyzing atrophy in local areas of the brain. This outstanding AI technology enables more accurate assessment of future dementia risk.
2.Receive results quicly
As a cloud-based software, medical professionals test for future dementia risk by uploading head MRI scans to SupportBrain® for analysis against a large database. Rapid analysis provides results in under 30 minutes. Reports provide easy-to-understand explanations for patients, helping them understand their health and make lifestyle changes.
3.Motivate patients to get tested and learn about dementia
As mentioned, SupportBrain® provides immediate results and clear information. We believe this combination will motivate patients to make better lifestyle choices.
Even though dementia is becoming a global issue with cases increasing each year not many people are interested in or take this disease seriously. SupportBrain® provides patients with opportunities to learn more about dementia, motivating them to get tested.
Testimonials From Patients
Learning about my current state of dementia gives me peace of mind. I want to be tested again if I have any other concerns.
I’m glad to know my current risk of dementia. I will continue testing regularly.
I want to test on a regular basis. I decided to do my daily brain exercises and encouraged by wife to get tested.
Results are delivered using easy-to-understand numbers. I will get regularly tested to monitor my progress.
I tested with SupportBrain® after other tests showed I suffer from some brain atrophy. My results indicated that I’m at low risk for dementia, but I would like to retest in three years.
I had no idea this type of test was available or I would have tested a long time ago.
Testimonials From Health Care Providers
Brain atrophy is difficult to diagnose through human observation. SupportBrain® is a useful tool that analyzes this atrophy with AI.
SupportBrain® can lead to bright futures for patients
SupportBrain® uses objective, convincing indicators, motivating patients to change their behaviors.
Analysis is immediate, allowing patients to receive same-day test results.
Results are best measured with numbers and the reports are easy to understand.
SupportBrain® analyzes the entire brain with AI, which allows for more rational analysis from a clinical point of view.
Testimonials From Companies and Municipalities
We would like to collaborate with ERISA as we expect that SupportBrain® will help us revitalize the market for dementia prevention.
Interest in brain health is high within our company for health management, so we will introduce SupportBrain® in our corporate medical checkups.
I think SupportBrain® is an attractive service for new business development and investment.
We introduced SupportBrain® as part of our services to prevent dementia. Reducing the risk of dementia in citizens benefits the municipality.
SupportBrain® is a ground-breaking service. We hope to offer this service to citizens on a large scale.
SupportBrain® is an advanced initiative commercialized through collaborations amongst industries, governments, and academia. We hope to join in and promote this service.
Proud Developer: ERISA Co., Ltd
A “BRAIN” that supports your individuality
ERISA develops necessary solutions to understand the brain.
Our unique brain analysis technology scans for a variety of brain diseases from Alzheimer's and other forms of dementia to psychiatric disorders such as depression and other central nervous system disorders.
Through SupportBrain®, ERISA aims to create safe societies as a company that supports individuality for all.
Click photos to enlarge
Company profile
Company name | ERISA Co., Ltd. |
---|---|
Home page | https://www.erisa.co.jp/ |
Outline of business | Research, development, and sales of brain image analysis technology using AI×OI |
Date of establishment | 2017 |
Capital | 82.5 million yen |
Number of employees | 10 |
For inquiries, please contact Overseas Expansion Support Office, Shimane Prefectural Government: kaigai-tenkai@pref.shimane.lg.jp